IN2015KO00249A - - Google Patents

Info

Publication number
IN2015KO00249A
IN2015KO00249A IN249KO2015A IN2015KO00249A IN 2015KO00249 A IN2015KO00249 A IN 2015KO00249A IN 249KO2015 A IN249KO2015 A IN 249KO2015A IN 2015KO00249 A IN2015KO00249 A IN 2015KO00249A
Authority
IN
India
Prior art keywords
cartilage
choncal
relates
preparing
microtia
Prior art date
Application number
Other languages
English (en)
Inventor
Kumar Nandi Dr Samit
Original Assignee
Kumar Nandi Dr Samit
Siddhartha Narayan Joardar Dr
Bikash Kanti Biswas Dr
Ms Piyali Das
Pradip Kumar Das Dr
Subhasish Batabyal Dr
Rupnarayan Bhattacharya Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kumar Nandi Dr Samit, Siddhartha Narayan Joardar Dr, Bikash Kanti Biswas Dr, Ms Piyali Das, Pradip Kumar Das Dr, Subhasish Batabyal Dr, Rupnarayan Bhattacharya Dr filed Critical Kumar Nandi Dr Samit
Priority to IN249KO2015 priority Critical patent/IN2015KO00249A/en
Publication of IN2015KO00249A publication Critical patent/IN2015KO00249A/en

Links

Landscapes

  • Materials For Medical Uses (AREA)
IN249KO2015 2015-03-09 2015-03-09 IN2015KO00249A (lt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN249KO2015 IN2015KO00249A (lt) 2015-03-09 2015-03-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN249KO2015 IN2015KO00249A (lt) 2015-03-09 2015-03-09

Publications (1)

Publication Number Publication Date
IN2015KO00249A true IN2015KO00249A (lt) 2015-04-17

Family

ID=54393580

Family Applications (1)

Application Number Title Priority Date Filing Date
IN249KO2015 IN2015KO00249A (lt) 2015-03-09 2015-03-09

Country Status (1)

Country Link
IN (1) IN2015KO00249A (lt)

Similar Documents

Publication Publication Date Title
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
MX2018015853A (es) Anticuerpos multiespecificos frente a los grupos de diferenciacion 40 y 137 (cd40 y cd137).
MX2017008813A (es) Polvo de coleopteros.
MX2017001281A (es) Material anisotropico biocompuesto, implantes medicos que lo comprenden y metodos para el tratamiento del mismo.
MX2021007268A (es) Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas.
JOP20200230A1 (ar) ناهضات ppar (مستقبل ناشر بيروكسيزوم منشط)، ومركبات، ومكونات أدوية، وطرق استعمالها
MX2017008815A (es) Composicion que contiene quitina y proteinas digeribles.
MX2017009417A (es) Formas solidas de acido 2-(5-(3-fluorofenil)-3-hidroxipicolinamido )acetico, composiciones y usos de las mismas.
NZ729417A (en) Compositions and methods for enhancing healing and regeneration of bone and soft tissue
MX2021004558A (es) Polimeros de union a protones para administracion oral.
TN2018000188A1 (en) Isoindole compounds
MX2022006817A (es) Formulaciones/composiciones que comprenden un inhibidor de btk.
MX2022002635A (es) Anticuerpos anti proteina similar a angiopoyetina 4 y metodos de uso.
PH12016502243A1 (en) Pharmaceutical compositions for treating infectious diseases
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
EP3326637A4 (en) USE OF MANGOSTINRINDENEXTRACT FOR THE PREPARATION OF MEDICINE FOR THE TREATMENT OF SKIN DISEASES
EP3253886A4 (en) Novel methods for early identification of bone healing ability in injured patients
EA201791346A1 (ru) ТВЕРДЫЕ ФОРМЫ, ВКЛЮЧАЮЩИЕ (1E,4E)-2-АМИНО-N,N-ДИПРОПИЛ-8-(4-(ПИРРОЛИДИН-1-КАРБОНИЛ)ФЕНИЛ)-3H-БЕНЗО[b]-АЗЕПИН-4-КАРБОКСАМИД, ИХ КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ
MX2016010873A (es) Factor de crecimiento de fibroblastos 18 en los procedimientos para el trasplante de injertos y para ingenieria de tejidos.
SG11201804307WA (en) Therapeutic agent for liver disease containing stromal cells derived from adipose tissue and method for producing the same
IN2015KO00249A (lt)
EP3274006A4 (en) Vascular casted prostheses and methods of forming same for treating biological tissue
TW201614066A (en) Composition for treatment of joint disease and method thereof
MX2018013885A (es) Métodos de tratamiento de enfermedades asociadas con células linfoides innatas del grupo 3 (cli3).
MX2019006886A (es) Métodos para tratar enfermedades asociadas con células linfoides innatas del grupo 2 (ilc2).